17 May 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
15 May 2024 - At the end of April 2024, Mao-Ting Sheen visited the Institute for Quality and Efficiency in Healthcare ...
15 May 2024 - Evidence about the comparative effects of new treatments is typically collected in randomised controlled trials (RCTs). In ...
15 May 2024 - NICE has published final evidence-based recommendations on the use of selinexor (Nexpovio) in combination with bortezomib ...
15 May 2024 - Health technology assessment guidance often recommends a 3% real annual discount rate, the appropriateness of which ...
15 May 2024 - NICE has published final evidence-based recommendations on atogepant monohydrate (Aquipta) for preventing migraine in adults. ...
14 May 2024 - There are substantial uncertainties around the clinical trial results; given the inability to assess net benefit, ...
13 May 2024 - The SMC has today published advice on two medicines. ...
13 May 2024 - PHARMAC is sharing what medicine applications will be considered at the Rare Disorders Advisory Committee meeting ...
8 May 2024 - NICE has published final evidence-based recommendations on the use of remdesivir (Veklury) and tixagevimab and cilgavimab ...
10 May 2024 - Discounting the cost and effect for health intervention is a controversial topic over the last two decades. ...
10 May 2024 - More people with early breast cancer could be spared chemotherapy and therefore avoid the side effects associated ...
10 May 2024 - The Department of Health has published a revised agenda for the July 2024 PBAC meeting. ...
9 May 2024 - Public comment period now open until 10 June 2024; requests to make oral comment during public ...
8 May 2024 - NICE has published evidence-based recommendations on the use of selinexor (Nexpovio) in combination with dexamethasone for ...